Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/22 → 31/12/22 |
Funding
- Diabetes Australia: A$69,068.00
Sulforaphane, a vasoprotective compound to reduce maternal vascular complications in human gestational diabetes
- Marshall, Sarah (Primary Chief Investigator (PCI))
- Tare, Marianne (Chief Investigator (CI))
- Wallace, Euan (Associate Investigator (AI))
Project: Research